인쇄하기
취소
|
A research result of Poziotinib, a targeted therapy for cancer developed by Hanmi Pharm, was registered in the online version of Nature Medicine, an international SCI(Science Citation Index) journal.
Spectrum Pharmaceuticals, a U.S. partner of Hanmi Pharm(CEO Sae-Chang Kwon & Jong-Soo Woo), announced this in a press release on the 23rd(local time), and mentioned possibilities to smoothly devel...